Subclinical pericarditis long after SARS-CoV-2 infection: a case report
https://doi.org/10.4081/ecj.2021.9782
Accepted: 20 April 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
We describe a rare complication of COVID-19 long after infection in a 76-years-old man presented to the Emergency Department with dyspnea and palpitations. A 12-lead Electrocardiogram (ECG) showed sinus tachycardia PR depression in the inferior leads associated with an apparent pseudo ST elevation. In the absence of elevation of inflammatory indices, considering the lack of symptoms neither NSAIDs nor colchicine were prescribed, and the patient was referred for clinical follow-up. After ten days ECG documented initial reduction of the widespread concave STE and PR depression, and the 1-month follow- up visit, the patient was asymptomatic with unremarkable physical examination, and a 12-lead ECG showed almost complete normalization of the ST and PR segments. Although pericardial involvement after COVID-19 infection has been already described, the incidence of subclinical pericarditis has not and may have implications for the monitoring of patients with uncomplicated COVID-19 infection managed as outpatients.
Carfì A, Bernabei R, Landi F, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324:603-5. DOI: https://doi.org/10.1001/jama.2020.12603
Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;S0163-4453(21)00009-8.
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:819-24. DOI: https://doi.org/10.1001/jamacardio.2020.1096
Fancello L, Monteil S, Popgeorgiev N, et al. Viral communities associated with human pericardial fluids in idiopathic pericarditis. PLoS One 2014;9:e93367. DOI: https://doi.org/10.1371/journal.pone.0093367
Linschoten M, Peters S, Van Smeden N, et al Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care 2020;9:817–23. DOI: https://doi.org/10.1177/2048872620974605
Linschoten M, Asselbergs FW. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic. Eur Heart J 2020;41:1795–6. DOI: https://doi.org/10.1093/eurheartj/ehaa280
Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-8. DOI: https://doi.org/10.1001/jamacardio.2020.1017
Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Post-acute COVID-19: An overview and approach to classification. Open Forum Infect Dis 2020;7:ofaa509. DOI: https://doi.org/10.1093/ofid/ofaa509
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
